Robust Microarray Meta-Analysis Identifies Differentially Expressed Genes for Clinical Prediction

Table 1

Microarray datasets.

(a) Breast cancer estrogen receptor status

Dataset	ER+	ER−	Platform	No. of probes
MDACC Train	80	50	Affy HG-U133A	22283
MDACC Test	60	40	Affy HG-U133A	22283
Miller	213	34	Affy HG-U133A	22283
Sotiriou	72	24	Affy HG-U133A	22283
Minn	57	42	Affy HG-U133A	22283
Van't Veer	226	69	Agilent 2-Color	24496

Common probes: 8953.

(b) Renal cancer subtype

Dataset	CC	Other	Platform	No. of probes
Schuetz	13	12	Affy HG-Focus	8793
Jones	32	29	Affy HG-U133A	22283
Kort	10	30	Affy HG-U133+2.0	54675
Yusenko	26	27	Affy HG-U133+2.0	54675
Higgins	26	9	cDNA 2-Color	22689

Common probes: 946.

(c) Pancreatic cancer diagnosis

Dataset	Normal	Cancer	Platform	No. of probes
Badea	39	39	Affy HG-U133+2.0	54675
Ishikawa	25	24	Affy HG-U133A/B	44928
Pei	16	36	Affy HG-U133+2.0	54675
Pilarsky	18	27	Affy HG-U133A/B	44928
Iacobuzio-Donahue	5	17	cDNA 2-Color	43910

Common probes: 4530.